Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a Phase 2 trial for its experimental drug ...

Last week's rumour that GSK was poised to make a bid to acquire IDRx and its experimental targeted therapy for a rare form of rare gastrointestinal cancer was on the money. This morning, the UK ...

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The annual meeting runs April 25 ...

Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer patient. The patient had to choose ...

NEW HAVEN, Conn. (WFSB) - Colon cancer rates are on the rise, especially in people under age 50, and doctors don’t fully understand why. While there’s no clear explanation for the increase ...

Anybody under 55, listen up—there has been a dramatic increase in the likelihood you or somebody you know will be diagnosed with colon cancer in early adulthood or middle age. And while the ...

Their findings comes amid a mysterious rise in colon cancer among young adults, with diagnoses having shot up 80 per cent in 30 years. In new study, Hungarian experts conducted an analysis of 50 ...

A leading doctor has warned of the five key signs of colon cancer, amid the 'alarming rise' of cases among Gen Z and Millennials. Internal medicine specialist Dr Zion Ko Lamm urged young people to ...

Now, researchers say this powerhouse vitamin may also play a crucial role in lowering risk for colorectal cancer, which has been on the rise in younger adults, becoming the leading cause of cancer ...

after a battle with stage 4 colon cancer. He was 70. The family confirmed his death on Tuesday, April 22. “At this time, we kindly ask for privacy as our family grieves this tremendous loss ...